+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Altretamine Market by Distribution Channel (Hospital Pharmacy, Retail Pharmacy), End User (Ambulatory Care Centers, Hospitals, Oncology Centers), Product Type - Global Forecast 2025-2030- Product Image
Altretamine Market by Distribution Channel (Hospital Pharmacy, Retail Pharmacy), End User (Ambulatory Care Centers, Hospitals, Oncology Centers), Product Type - Global Forecast 2025-2030- Product Image
Sale

Altretamine Market by Distribution Channel (Hospital Pharmacy, Retail Pharmacy), End User (Ambulatory Care Centers, Hospitals, Oncology Centers), Product Type - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 196 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6015156
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The altretamine market is entering a period of transition shaped by advances in formulation technologies, changes in the reimbursement landscape, and evolving clinical practices in oncology. As therapeutic strategies diversify and new regulatory and economic pressures emerge, senior decision-makers are reevaluating how altretamine fits across treatment modalities and geographies.

Market Snapshot: Altretamine Market Size and Growth

The Altretamine Market grew from USD 141.33 million in 2024 to USD 147.53 million in 2025. It is expected to continue growing at a CAGR of 4.35%, reaching USD 182.48 million by 2030. This stable trajectory reflects sustained demand within oncology practice as well as ongoing investment in innovation and supply chain resilience.

Scope & Segmentation of the Altretamine Market

Comprehensive market assessment encompasses all major stakeholders and factors influencing adoption. The report details the following segmentation:

  • Distribution Channels: Hospital pharmacy, retail pharmacy
  • Hospital Pharmacy Types: Private hospitals, public hospitals
  • Retail Pharmacy Types: Chain pharmacies, independent pharmacies
  • End Users: Ambulatory care centers, hospitals, oncology centers, specialty clinics
  • Product Types: Branded and generic altretamine formulations
  • Regions: Americas (with focus countries and states such as United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland), and Asia-Pacific (including China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan)
  • Recent Company Developments: Assessed across leading industry participants, including Teva Pharmaceutical Industries Ltd., Viatris Inc., Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Limited, Amneal Pharmaceuticals, Inc., Apotex Inc., Camber Pharmaceuticals, Inc., Sagent Pharmaceuticals, Inc., Alembic Pharmaceuticals Limited, and Bristol-Myers Squibb Company

Key Takeaways for Senior Decision-Makers

  • Clinical interest in altretamine is evolving due to its integration in combination regimens and advances in personalized therapy, broadening the drug’s strategic applications across multiple oncology segments.
  • Innovative delivery technologies such as nanoparticle carriers are improving bioavailability and patient adherence, offering differentiation avenues for product portfolios.
  • Access models are shifting toward value-based agreements, directly linking reimbursement to real-world outcomes—reflecting new dynamics in payer negotiations that require adaptive strategy.
  • Increasing adoption of digital health platforms for patient monitoring and adherence support presents opportunities for enhanced therapeutic outcomes and operational efficiency.
  • The market is characterized by active collaboration between pharmaceutical manufacturers, health systems, and public-private alliances to drive supply chain resilience and regulatory compliance.
  • Branded formulations tend to enjoy physician preference and higher awareness, while generics expand market reach and cost competitiveness, especially in emerging markets and budget-conscious health systems.

Tariff Impact on the Altretamine Market

Recent United States pharmaceutical tariffs in 2025 have increased import costs for altretamine’s key intermediates, prompting manufacturers to consider local sourcing and regional partnerships to minimize margin pressure. Tariff reforms are influencing pricing negotiations with payers, while healthcare providers adapt through formulary realignment and in-state production initiatives. Patient advocacy organizations are responding with support programs to offset co-payment changes and maintain access.

Methodology & Data Sources

This report is based on a robust research framework combining quantitative and qualitative data. Expert interviews with oncology professionals, pharmacy directors, and industry leaders supplement findings from regulatory filings, clinical trial databases, and proprietary market intelligence. Validation protocols and analytical modelling ensure a reliable foundation for strategic recommendations.

Why This Report Matters

  • Supports informed decision-making on portfolio development, procurement strategies, and geographic expansion within the altretamine market.
  • Provides clarity on regional dynamics, local access models, and technology adoption, enabling effective resource allocation and risk management.
  • Equips senior executives with actionable intelligence to navigate regulatory complexities, competitive shifts, and multi-stakeholder engagement in oncology care.

Conclusion

The altretamine market is evolving alongside regulatory, technological, and clinical advancements. This report offers clear insights for leaders seeking to optimize strategy, ensure supply resilience, and capitalize on new opportunities in oncology therapeutics.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Increasing adoption of personalized dosing regimens for altretamine to improve patient outcomes
5.2. Emerging research on nanoparticle formulations enhancing altretamine delivery and bioavailability
5.3. Strategic collaborations between biopharma companies focusing on combination therapies with altretamine
5.4. Shift in clinical trial designs exploring altretamine for novel hematological cancer indications
5.5. Regulatory scrutiny on altretamine manufacturing processes driving quality standard enhancements
5.6. Market penetration challenges in emerging economies due to high cost and limited altretamine availability
5.7. Integration of real-world evidence studies demonstrating long-term safety of altretamine in diverse populations
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Altretamine Market, by Distribution Channel
8.1. Introduction
8.2. Hospital Pharmacy
8.2.1. Private Hospital
8.2.2. Public Hospital
8.3. Retail Pharmacy
8.3.1. Chain Pharmacy
8.3.2. Independent Pharmacy
9. Altretamine Market, by End User
9.1. Introduction
9.2. Ambulatory Care Centers
9.3. Hospitals
9.4. Oncology Centers
9.5. Specialty Clinics
10. Altretamine Market, by Product Type
10.1. Introduction
10.2. Branded
10.3. Generic
11. Americas Altretamine Market
11.1. Introduction
11.2. United States
11.3. Canada
11.4. Mexico
11.5. Brazil
11.6. Argentina
12. Europe, Middle East & Africa Altretamine Market
12.1. Introduction
12.2. United Kingdom
12.3. Germany
12.4. France
12.5. Russia
12.6. Italy
12.7. Spain
12.8. United Arab Emirates
12.9. Saudi Arabia
12.10. South Africa
12.11. Denmark
12.12. Netherlands
12.13. Qatar
12.14. Finland
12.15. Sweden
12.16. Nigeria
12.17. Egypt
12.18. Turkey
12.19. Israel
12.20. Norway
12.21. Poland
12.22. Switzerland
13. Asia-Pacific Altretamine Market
13.1. Introduction
13.2. China
13.3. India
13.4. Japan
13.5. Australia
13.6. South Korea
13.7. Indonesia
13.8. Thailand
13.9. Philippines
13.10. Malaysia
13.11. Singapore
13.12. Vietnam
13.13. Taiwan
14. Competitive Landscape
14.1. Market Share Analysis, 2024
14.2. FPNV Positioning Matrix, 2024
14.3. Competitive Analysis
14.3.1. Teva Pharmaceutical Industries Ltd.
14.3.2. Viatris Inc.
14.3.3. Sun Pharmaceutical Industries Ltd.
14.3.4. Aurobindo Pharma Limited
14.3.5. Amneal Pharmaceuticals, Inc.
14.3.6. Apotex Inc.
14.3.7. Camber Pharmaceuticals, Inc.
14.3.8. Sagent Pharmaceuticals, Inc.
14.3.9. Alembic Pharmaceuticals Limited
14.3.10. Bristol-Myers Squibb Company
15. ResearchAI
16. ResearchStatistics
17. ResearchContacts
18. ResearchArticles
19. Appendix
List of Figures
FIGURE 1. ALTRETAMINE MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL ALTRETAMINE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL ALTRETAMINE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL ALTRETAMINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL ALTRETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 6. GLOBAL ALTRETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ALTRETAMINE MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ALTRETAMINE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ALTRETAMINE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ALTRETAMINE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. AMERICAS ALTRETAMINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 12. AMERICAS ALTRETAMINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. UNITED STATES ALTRETAMINE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 14. UNITED STATES ALTRETAMINE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. EUROPE, MIDDLE EAST & AFRICA ALTRETAMINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. EUROPE, MIDDLE EAST & AFRICA ALTRETAMINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC ALTRETAMINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC ALTRETAMINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ALTRETAMINE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 20. ALTRETAMINE MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 21. ALTRETAMINE MARKET: RESEARCHAI
FIGURE 22. ALTRETAMINE MARKET: RESEARCHSTATISTICS
FIGURE 23. ALTRETAMINE MARKET: RESEARCHCONTACTS
FIGURE 24. ALTRETAMINE MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. ALTRETAMINE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ALTRETAMINE MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL ALTRETAMINE MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL ALTRETAMINE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL ALTRETAMINE MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL ALTRETAMINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL ALTRETAMINE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL ALTRETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL ALTRETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL ALTRETAMINE MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL ALTRETAMINE MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL ALTRETAMINE MARKET SIZE, BY PRIVATE HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL ALTRETAMINE MARKET SIZE, BY PRIVATE HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL ALTRETAMINE MARKET SIZE, BY PUBLIC HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL ALTRETAMINE MARKET SIZE, BY PUBLIC HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL ALTRETAMINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL ALTRETAMINE MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL ALTRETAMINE MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL ALTRETAMINE MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL ALTRETAMINE MARKET SIZE, BY CHAIN PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL ALTRETAMINE MARKET SIZE, BY CHAIN PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL ALTRETAMINE MARKET SIZE, BY INDEPENDENT PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL ALTRETAMINE MARKET SIZE, BY INDEPENDENT PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL ALTRETAMINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL ALTRETAMINE MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL ALTRETAMINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL ALTRETAMINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL ALTRETAMINE MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL ALTRETAMINE MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL ALTRETAMINE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL ALTRETAMINE MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL ALTRETAMINE MARKET SIZE, BY ONCOLOGY CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL ALTRETAMINE MARKET SIZE, BY ONCOLOGY CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL ALTRETAMINE MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL ALTRETAMINE MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL ALTRETAMINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL ALTRETAMINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL ALTRETAMINE MARKET SIZE, BY BRANDED, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL ALTRETAMINE MARKET SIZE, BY BRANDED, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL ALTRETAMINE MARKET SIZE, BY GENERIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL ALTRETAMINE MARKET SIZE, BY GENERIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. AMERICAS ALTRETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 44. AMERICAS ALTRETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 45. AMERICAS ALTRETAMINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 46. AMERICAS ALTRETAMINE MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 47. AMERICAS ALTRETAMINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 48. AMERICAS ALTRETAMINE MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 49. AMERICAS ALTRETAMINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 50. AMERICAS ALTRETAMINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 51. AMERICAS ALTRETAMINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 52. AMERICAS ALTRETAMINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 53. AMERICAS ALTRETAMINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 54. AMERICAS ALTRETAMINE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 55. UNITED STATES ALTRETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 56. UNITED STATES ALTRETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 57. UNITED STATES ALTRETAMINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 58. UNITED STATES ALTRETAMINE MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 59. UNITED STATES ALTRETAMINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 60. UNITED STATES ALTRETAMINE MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 61. UNITED STATES ALTRETAMINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 62. UNITED STATES ALTRETAMINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 63. UNITED STATES ALTRETAMINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 64. UNITED STATES ALTRETAMINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 65. UNITED STATES ALTRETAMINE MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 66. UNITED STATES ALTRETAMINE MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 67. CANADA ALTRETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 68. CANADA ALTRETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 69. CANADA ALTRETAMINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 70. CANADA ALTRETAMINE MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 71. CANADA ALTRETAMINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 72. CANADA ALTRETAMINE MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 73. CANADA ALTRETAMINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 74. CANADA ALTRETAMINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 75. CANADA ALTRETAMINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 76. CANADA ALTRETAMINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 77. MEXICO ALTRETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 78. MEXICO ALTRETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 79. MEXICO ALTRETAMINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 80. MEXICO ALTRETAMINE MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 81. MEXICO ALTRETAMINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 82. MEXICO ALTRETAMINE MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 83. MEXICO ALTRETAMINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 84. MEXICO ALTRETAMINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 85. MEXICO ALTRETAMINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 86. MEXICO ALTRETAMINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 87. BRAZIL ALTRETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 88. BRAZIL ALTRETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 89. BRAZIL ALTRETAMINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 90. BRAZIL ALTRETAMINE MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 91. BRAZIL ALTRETAMINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 92. BRAZIL ALTRETAMINE MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 93. BRAZIL ALTRETAMINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 94. BRAZIL ALTRETAMINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 95. BRAZIL ALTRETAMINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 96. BRAZIL ALTRETAMINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 97. ARGENTINA ALTRETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 98. ARGENTINA ALTRETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 99. ARGENTINA ALTRETAMINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 100. ARGENTINA ALTRETAMINE MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 101. ARGENTINA ALTRETAMINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 102. ARGENTINA ALTRETAMINE MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 103. ARGENTINA ALTRETAMINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 104. ARGENTINA ALTRETAMINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 105. ARGENTINA ALTRETAMINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 106. ARGENTINA ALTRETAMINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA ALTRETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 108. EUROPE, MIDDLE EAST & AFRICA ALTRETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 109. EUROPE, MIDDLE EAST & AFRICA ALTRETAMINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 110. EUROPE, MIDDLE EAST & AFRICA ALTRETAMINE MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 111. EUROPE, MIDDLE EAST & AFRICA ALTRETAMINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 112. EUROPE, MIDDLE EAST & AFRICA ALTRETAMINE MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 113. EUROPE, MIDDLE EAST & AFRICA ALTRETAMINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 114. EUROPE, MIDDLE EAST & AFRICA ALTRETAMINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 115. EUROPE, MIDDLE EAST & AFRICA ALTRETAMINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 116. EUROPE, MIDDLE EAST & AFRICA ALTRETAMINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 117. EUROPE, MIDDLE EAST & AFRICA ALTRETAMINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 118. EUROPE, MIDDLE EAST & AFRICA ALTRETAMINE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 119. UNITED KINGDOM ALTRETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 120. UNITED KINGDOM ALTRETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 121. UNITED KINGDOM ALTRETAMINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 122. UNITED KINGDOM ALTRETAMINE MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 123. UNITED KINGDOM ALTRETAMINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 124. UNITED KINGDOM ALTRETAMINE MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 125. UNITED KINGDOM ALTRETAMINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 126. UNITED KINGDOM ALTRETAMINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 127. UNITED KINGDOM ALTRETAMINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 128. UNITED KINGDOM ALTRETAMINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 129. GERMANY ALTRETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 130. GERMANY ALTRETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 131. GERMANY ALTRETAMINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 132. GERMANY ALTRETAMINE MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 133. GERMANY ALTRETAMINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 134. GERMANY ALTRETAMINE MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 135. GERMANY ALTRETAMINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 136. GERMANY ALTRETAMINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 137. GERMANY ALTRETAMINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 138. GERMANY ALTRETAMINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 139. FRANCE ALTRETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 140. FRANCE ALTRETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 141. FRANCE ALTRETAMINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 142. FRANCE ALTRETAMINE MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 143. FRANCE ALTRETAMINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 144. FRANCE ALTRETAMINE MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 145. FRANCE ALTRETAMINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 146. FRANCE ALTRETAMINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 147. FRANCE ALTRETAMINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 148. FRANCE ALTRETAMINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 149. RUSSIA ALTRETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 150. RUSSIA ALTRETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 151. RUSSIA ALTRETAMINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 152. RUSSIA ALTRETAMINE MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 153. RUSSIA ALTRETAMINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 154. RUSSIA ALTRETAMINE MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 155. RUSSIA ALTRETAMINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 156. RUSSIA ALTRETAMINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 157. RUSSIA ALTRETAMINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 158. RUSSIA ALTRETAMINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 159. ITALY ALTRETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 160. ITALY ALTRETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 161. ITALY ALTRETAMINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 162. ITALY ALTRETAMINE MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 163. ITALY ALTRETAMINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 164. ITALY ALTRETAMINE MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 165. ITALY ALTRETAMINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 166. ITALY ALTRETAMINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 167. ITALY ALTRETAMINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 168. ITALY ALTRETAMINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 169. SPAIN ALTRETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 170. SPAIN ALTRETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 171. SPAIN ALTRETAMINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 172. SPAIN ALTRETAMINE MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 173. SPAIN ALTRETAMINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 174. SPAIN ALTRETAMINE MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 175. SPAIN ALTRETAMINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 176. SPAIN ALTRETAMINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 177. SPAIN ALTRETAMINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 178. SPAIN ALTRETAMINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 179. UNITED ARAB EMIRATES ALTRETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 180. UNITED ARAB EMIRATES ALTRETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 181. UNITED ARAB EMIRATES ALTRETAMINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 182. UNITED ARAB EMIRATES ALTRETAMINE MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 183. UNITED ARAB EMIRATES ALTRETAMINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 184. UNITED ARAB EMIRATES ALTRETAMINE MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 185. UNITED ARAB EMIRATES ALTRETAMINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 186. UNITED ARAB EMIRATES ALTRETAMINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 187. UNITED ARAB EMIRATES ALTRETAMINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 188. UNITED ARAB EMIRATES ALTRETAMINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 189. SAUDI ARABIA ALTRETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 190. SAUDI ARABIA ALTRETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 191. SAUDI ARABIA ALTRETAMINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 192. SAUDI ARABIA ALTRETAMINE MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 193. SAUDI ARABIA ALTRETAMINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 194. SAUDI ARABIA ALTRETAMINE MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 195. SAUDI ARABIA ALTRETAMINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 196. SAUDI ARABIA ALTRETAMINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 197. SAUDI ARABIA ALTRETAMINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 198. SAUDI ARABIA ALTRETAMINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 199. SOUTH AFRICA ALTRETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 200. SOUTH AFRICA ALTRETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 201. SOUTH AFRICA ALTRETAMINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 202. SOUTH AFRICA ALTRETAMINE MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 203. SOUTH AFRICA ALTRETAMINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 204. SOUTH AFRICA ALTRETAMINE MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 205. SOUTH AFRICA ALTRETAMINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 206. SOUTH AFRICA ALTRETAMINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 207. SOUTH AFRICA ALTRETAMINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 208. SOUTH AFRICA ALTRETAMINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 209. DENMARK ALTRETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 210. DENMARK ALTRETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 211. DENMARK ALTRETAMINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 212. DENMARK ALTRETAMINE MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 213. DENMARK ALTRETAMINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 214. DENMARK ALTRETAMINE MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 215. DENMARK ALTRETAMINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 216. DENMARK ALTRETAMINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 217. DENMARK ALTRETAMINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 218. DENMARK ALTRETAMINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 219. NETHERLANDS ALTRETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 220. NETHERLANDS ALTRETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 221. NETHERLANDS ALTRETAMINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 222. NETHERLANDS ALTRETAMINE MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 223. NETHERLANDS ALTRETAMINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 224. NETHERLANDS ALTRETAMINE MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 225. NETHERLANDS ALTRETAMINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 226. NETHERLANDS ALTRETAMINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 227. NETHERLANDS ALTRETAMINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 228. NETHERLANDS ALTRETAMINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 229. QATAR ALTRETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 230. QATAR ALTRETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 231. QATAR ALTRETAMINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 232. QATAR ALTRETAMINE MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 233. QATAR ALTRETAMINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 234. QATAR ALTRETAMINE MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 235. QATAR ALTRETAMINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 236. QATAR ALTRETAMINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 237. QATAR ALTRETAMINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 238. QATAR ALTRETAMINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 239. FINLAND ALTRETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 240. FINLAND ALTRETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 241. FINLAND ALTRETAMINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 242. FINLAND ALTRETAMINE MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 243. FINLAND ALTRETAMINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 244. FINLAND ALTRETAMINE MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 245. FINLAND ALTRETAMINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 246. FINLAND ALTRETAMINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 247. FINLAND ALTRETAMINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 248. FINLAND ALTRETAMINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 249. SWEDEN ALTRETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 250. SWEDEN ALTRETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 251. SWEDEN ALTRETAMINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 252. SWEDEN ALTRETAMINE MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 253. SWEDEN ALTRETAMINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 254. SWEDEN ALTRETAMINE MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 255. SWEDEN ALTRETAMINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 256. SWEDEN ALTRETAMINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 257. SWEDEN ALTRETAMINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 258. SWEDEN ALTRETAMINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 259. NIGERIA ALTRETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 260. NIGERIA ALTRETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 261. NIGERIA ALTRETAMINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 262. NIGERIA ALTRETAMINE MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 263. NIGERIA ALTRETAMINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 264. NIGERIA ALTRETAMINE MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 265. NIGERIA ALTRETAMINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 266. NIGERIA ALTRETAMINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 267. NIGERIA ALTRETAMINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 268. NIGERIA ALTRETAMINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 269. EGYPT ALTRETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 270. EGYPT ALTRETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 271. EGYPT ALTRETAMINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 272. EGYPT ALTRETAMINE MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 273. EGYPT ALTRETAMINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 274. EGYPT ALTRETAMINE MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 275. EGYPT ALTRETAMINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 276. EGYPT ALTRETAMINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 277. EGYPT ALTRETAMINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 278. EGYPT ALTRETAMINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 279. TURKEY ALTRETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 280. TURKEY ALTRETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 281. TURKEY ALTRETAMINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 282. TURKEY ALTRETAMINE MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 283. TURKEY ALTRETAMINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 284. TURKEY ALTRETAMINE MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 285. TURKEY ALTRETAMINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 286. TURKEY ALTRETAMINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 287. TURKEY ALTRETAMINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 288. TURKEY ALTRETAMINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 289. ISRAEL ALTRETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 290. ISRAEL ALTRETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 291. ISRAEL ALTRETAMINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 292. ISRAEL ALTRETAMINE MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 293. ISRAEL ALTRETAMINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 294. ISRAEL ALTRETAMINE MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 295. ISRAEL ALTRETAMINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 296. ISRAEL ALTRETAMINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 297. ISRAEL ALTRETAMINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 298. ISRAEL ALTRETAMINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 299. NORWAY ALTRETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 300. NORWAY ALTRETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 301. NORWAY ALTRETAMINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 302. NORWAY ALTRETAMINE MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 303. NORWAY ALTRETAMINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 304. NORWAY ALTRETAMINE MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 305. NORWAY ALTRETAMINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 306. NORWAY ALTRETAMINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 307. NORWAY ALTRETAMINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 308. NORWAY ALTRETAMINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 309. POLAND ALTRETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 310. POLAND ALTRETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 311. POLAND ALTRETAMINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 312. POLAND ALTRETAMINE MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 313. POLAND ALTRETAMINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 314. POLAND ALTRETAMINE MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 315. POLAND ALTRETAMINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 316. POLAND ALTRETAMINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 317. POLAND ALTRETAMINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 318. POLAND ALTRETAMINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 319. SWITZERLAND ALTRETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 320. SWITZERLAND ALTRETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 321. SWITZERLAND ALTRETAMINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 322. SWITZERLAND ALTRETAMINE MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 323. SWITZERLAND ALTRETAMINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 324. SWITZERLAND ALTRETAMINE MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 325. SWITZERLAND ALTRETAMINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 326. SWITZERLAND ALTRETAMINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 327. SWITZERLAND ALTRETAMINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 328. SWITZERLAND ALTRETAMINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 329. ASIA-PACIFIC ALTRETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 330. ASIA-PACIFIC ALTRETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 331. ASIA-PACIFIC ALTRETAMINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 332. ASIA-PACIFIC ALTRETAMINE MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 333. ASIA-PACIFIC ALTRETAMINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 334. ASIA-PACIFIC ALTRETAMINE MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 335. ASIA-PACIFIC ALTRETAMINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 336. ASIA-PACIFIC ALTRETAMINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 337. ASIA-PACIFIC ALTRETAMINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 338. ASIA-PACIFIC ALTRETAMINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 339. ASIA-PACIFIC ALTRETAMINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 340. ASIA-PACIFIC ALTRETAMINE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 341. CHINA ALTRETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 342. CHINA ALTRETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 343. CHINA ALTRETAMINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 344. CHINA ALTRETAMINE MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 345. CHINA ALTRETAMINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 346. CHINA ALTRETAMINE MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 347. CHINA ALTRETAMINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 348. CHINA ALTRETAMINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 349. CHINA ALTRETAMINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 350. CHINA ALTRETAMINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 351. INDIA ALTRETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 352. INDIA ALTRETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 353. INDIA ALTRETAMINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 354. INDIA ALTRETAMINE MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 355. INDIA ALTRETAMINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 356. INDIA ALTRETAMINE MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 357. INDIA ALTRETAMINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 358. INDIA ALTRETAMINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 359. INDIA ALTRETAMINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 360. INDIA ALTRETAMINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 361. JAPAN ALTRETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 362. JAPAN ALTRETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 363. JAPAN ALTRETAMINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 364. JAPAN ALTRETAMINE MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 365. JAPAN ALTRETAMINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 366. JAPAN ALTRETAMINE MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 367. JAPAN ALTRETAMINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 368. JAPAN ALTRETAMINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 369. JAPAN ALTRETAMINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 370. JAPAN ALTRETAMINE

Samples

Loading
LOADING...

Companies Mentioned

The major companies profiled in this Altretamine market report include:
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.
  • Sun Pharmaceutical Industries Ltd.
  • Aurobindo Pharma Limited
  • Amneal Pharmaceuticals, Inc.
  • Apotex Inc.
  • Camber Pharmaceuticals, Inc.
  • Sagent Pharmaceuticals, Inc.
  • Alembic Pharmaceuticals Limited
  • Bristol-Myers Squibb Company

Table Information

Report AttributeDetails
No. of Pages196
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 147.53 Million
Forecasted Market Value ( USD ) by 2030 $ 182.48 Million
Compound Annual Growth Rate4.3%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Altretamine (CAS 645-05-6) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - Product Image

Altretamine (CAS 645-05-6) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029

  • Report
  • 50 Pages
  • Global
From
Prefilled Methotrexate Injection Market by Type (Branded, Generic), Indication (Crohn Disease, Juvenile Idiopathic Arthritis, Psoriasis), End User, Distribution Channel, Strength - Global Forecast 2025-2030 - Product Image

Prefilled Methotrexate Injection Market by Type (Branded, Generic), Indication (Crohn Disease, Juvenile Idiopathic Arthritis, Psoriasis), End User, Distribution Channel, Strength - Global Forecast 2025-2030

  • Report
  • 189 Pages
  • Global
From
Olaparib Tablets Market by Indication (Breast Cancer, Ovarian Cancer, Pancreatic Cancer), Line of Therapy (First Line, Maintenance, Second Line), Distribution Channel, Dosage Strength - Global Forecast 2025-2030 - Product Image

Olaparib Tablets Market by Indication (Breast Cancer, Ovarian Cancer, Pancreatic Cancer), Line of Therapy (First Line, Maintenance, Second Line), Distribution Channel, Dosage Strength - Global Forecast 2025-2030

  • Report
  • 199 Pages
  • Global
From
Doxorubicin Market Size, Share & Trends Analysis Report By Drug Formulation (Lyophilized Powder, Doxorubicin Injection), By Application, By Distribution Channel, By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Doxorubicin Market Size, Share & Trends Analysis Report By Drug Formulation (Lyophilized Powder, Doxorubicin Injection), By Application, By Distribution Channel, By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 80 Pages
  • Global
From
Doxorubicin Market Report by Application, Distribution Channel, and Region 2025-2033 - Product Image

Doxorubicin Market Report by Application, Distribution Channel, and Region 2025-2033

  • Report
  • 142 Pages
  • Global
From

About the Altretamine Market

Altretamine is a chemotherapy drug used to treat ovarian cancer. It is classified as an alkylating agent, meaning it works by damaging the DNA of cancer cells, preventing them from growing and dividing. Altretamine is usually used in combination with other chemotherapy drugs, such as cisplatin or carboplatin. It is typically administered intravenously, and is usually given in cycles of three to six weeks. Common side effects of altretamine include nausea, vomiting, hair loss, fatigue, and anemia. Altretamine is a relatively new drug, and is not widely used in the treatment of ovarian cancer. However, it has been shown to be effective in some cases, and is often used in combination with other chemotherapy drugs. It is also used in combination with other treatments, such as radiation therapy and surgery. The altretamine market is a small but growing one, with several companies developing and marketing the drug. These include Teva Pharmaceuticals, Mylan Pharmaceuticals, and Sun Pharmaceuticals. Other companies, such as Pfizer and Merck, are also researching and developing new formulations of altretamine. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.